FACS analysis showed that the glioblastoma CD133+ cells expressed the typical mesenchymal markers CD29, CD44 (hyaluronic receptor), CD73, CD90, CD105 (endoglin) and CD166. This evidence concerns the gene ITGB1 and glioblastoma.